A $41.7 million settlement has been reached in the antitrust class action filed against BuSpar maker Bristol-Myers Squibb. The suit claimed that the company had conspired with a potential competitor to prevent the entry into the market of a generic version of the drug, which is used to treat Generalized Anxiety Disorder and other disorders, including Alzheimer's Disease. (Jun-19-03) [SETTLEMENT WEBSITE]
Stay Informed
Get the latest on class action lawsuits, settlements & more! Subscribe to our free weekly newsletter.
Get our Newsletter!
Submit a New Complaint
Been wronged by a similar product or service?
Click here to send us your complaint.
Settlements
- BMS Settles with California for $23 Million
- BMS $403 Million in Settlements for Prescription Drug Pricing Suits
